EHAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Enhabit Inc (EHAB) is not a strong buy for a beginner investor with a long-term horizon at this time. While the stock has some positive catalysts like analyst upgrades and operational improvements, the financial performance shows significant declines in net income and EPS, and technical indicators do not suggest a strong upward momentum. Additionally, options data and trading sentiment are neutral, and there are no recent news or significant trading trends to act as a catalyst.
The stock's MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 59.042, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 11.134, R1: 11.386, S1: 10.882, R2: 11.542, S2: 10.726.
Oppenheimer upgraded the stock to Outperform with a $14 price target, citing strong demand, stable regulatory environment, and improving labor trends.
Improved reimbursement visibility and cost-saving initiatives noted by Jefferies.
Financial performance shows a significant decline in net income (-110.07% YoY) and EPS (-110.00% YoY) in Q3
Truist views the stock's risk/reward as balanced and initiated coverage with a Hold rating and $10.50 price target.
Stock trend analysis indicates a potential decline in the short term (-0.42% next day, -2.9% next week).
In Q3 2025, revenue increased by 3.94% YoY to $263.6M, but net income dropped by -110.07% YoY to $11.1M, and EPS fell by -110.00% YoY to $0.22. Gross margin improved slightly by 3.50% YoY to 46.4%.
Analysts have mixed views. Oppenheimer upgraded the stock to Outperform with a $14 price target, citing strong demand and operational improvements. Jefferies raised the price target to $12 and reiterated a Buy rating. Truist initiated coverage with a Hold rating and a $10.50 price target, citing balanced risk/reward.
